Literature DB >> 28673422

Human African trypanosomiasis.

Philippe Büscher1, Giuliano Cecchi2, Vincent Jamonneau3, Gerardo Priotto4.   

Abstract

Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost invariably progresses to death unless treated. Human African trypanosomiasis caused devastating epidemics during the 20th century. Thanks to sustained and coordinated efforts over the past 15 years, the number of reported cases has fallen to an historically low level. Fewer than 3000 cases were reported in 2015, and the disease is targeted for elimination by WHO. Despite these recent successes, the disease is still endemic in parts of sub-Saharan Africa, where it is a considerable burden on rural communities, most notably in central Africa. Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas. In the absence of a vaccine, disease control relies on case detection and treatment, and vector control. Available drugs are suboptimal, but ongoing clinical trials provide hope for safer and simpler treatments.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28673422     DOI: 10.1016/S0140-6736(17)31510-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  171 in total

1.  Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.

Authors:  Julien Pedron; Clotilde Boudot; Sébastien Hutter; Sandra Bourgeade-Delmas; Jean-Luc Stigliani; Alix Sournia-Saquet; Alain Moreau; Elisa Boutet-Robinet; Lucie Paloque; Emmanuelle Mothes; Michèle Laget; Laure Vendier; Geneviève Pratviel; Susan Wyllie; Alan Fairlamb; Nadine Azas; Bertrand Courtioux; Alexis Valentin; Pierre Verhaeghe
Journal:  Eur J Med Chem       Date:  2018-06-05       Impact factor: 6.514

2.  Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development.

Authors:  Kelly A Bachovchin; Amrita Sharma; Seema Bag; Dana M Klug; Katherine M Schneider; Baljinder Singh; Hitesh B Jalani; Melissa J Buskes; Naimee Mehta; Scott Tanghe; Jeremiah D Momper; Richard J Sciotti; Ana Rodriguez; Kojo Mensa-Wilmot; Michael P Pollastri; Lori Ferrins
Journal:  J Med Chem       Date:  2019-01-10       Impact factor: 7.446

3.  Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei.

Authors:  Glaécia An Pereira; Lucianna H Santos; Steven C Wang; Luan C Martins; Filipe S Villela; Weiting Liao; Marco A Dessoy; Luiz C Dias; Adriano D Andricopulo; Mariana Af Costa; Ronaldo Ap Nagem; Conor R Caffrey; Klaus R Liedl; Ernesto R Caffarena; Rafaela S Ferreira
Journal:  Future Med Chem       Date:  2019-07       Impact factor: 3.808

4.  Trypanosomatid Deoxyhypusine Synthase Activity Is Dependent on Shared Active-Site Complementation between Pseudoenzyme Paralogs.

Authors:  Gustavo A Afanador; Diana R Tomchick; Margaret A Phillips
Journal:  Structure       Date:  2018-09-06       Impact factor: 5.006

5.  TbSmee1 regulates hook complex morphology and the rate of flagellar pocket uptake in Trypanosoma brucei.

Authors:  Jenna A Perry; Amy N Sinclair-Davis; Michael R McAllaster; Christopher L de Graffenried
Journal:  Mol Microbiol       Date:  2017-12-18       Impact factor: 3.501

6.  Molecular identification of different trypanosome species in tsetse flies caught in the wildlife reserve of Santchou in the western region of Cameroon.

Authors:  Cyrille Nguemnang Kamdem; Arnol Auvaker Zebaze Tiofack; Estelle Mezajou Mewamba; Elvis Amih Ofon; Emmanuel Boris Djoumessi Gomseu; Gustave Simo
Journal:  Parasitol Res       Date:  2020-01-31       Impact factor: 2.289

7.  8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.

Authors:  Cyril Fersing; Clotilde Boudot; Julien Pedron; Sébastien Hutter; Nicolas Primas; Caroline Castera-Ducros; Sandra Bourgeade-Delmas; Alix Sournia-Saquet; Alain Moreau; Anita Cohen; Jean-Luc Stigliani; Geneviève Pratviel; Maxime D Crozet; Susan Wyllie; Alan Fairlamb; Alexis Valentin; Pascal Rathelot; Nadine Azas; Bertrand Courtioux; Pierre Verhaeghe; Patrice Vanelle
Journal:  Eur J Med Chem       Date:  2018-08-01       Impact factor: 6.514

8.  In Vitro and In Vivo Studies of the Trypanocidal Effect of Novel Quinolines.

Authors:  A S G Nefertiti; M M Batista; P B Da Silva; D G J Batista; C F Da Silva; R B Peres; E C Torres-Santos; E F Cunha-Junior; E Holt; D W Boykin; R Brun; T Wenzler; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

9.  Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor.

Authors:  Anh Tuan Tran; Aude Sadet; Paolo Calligari; Philippe Lopes; Jamal Ouazzani; Matthieu Sollogoub; Emeric Miclet; Daniel Abergel
Journal:  Biophys J       Date:  2018-11-06       Impact factor: 4.033

10.  An invariant Trypanosoma vivax vaccine antigen induces protective immunity.

Authors:  Delphine Autheman; Cécile Crosnier; Simon Clare; David A Goulding; Cordelia Brandt; Katherine Harcourt; Charlotte Tolley; Francis Galaway; Malhar Khushu; Han Ong; Alessandra Romero-Ramirez; Craig W Duffy; Andrew P Jackson; Gavin J Wright
Journal:  Nature       Date:  2021-05-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.